These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2086458)

  • 1. Variable linking region immunogenicity using malarial peptide carrier protein conjugates of defined composition.
    Jones GL; Spencer L; Mollard R; Saul A
    Immunol Lett; 1990 Dec; 26(3):285-90. PubMed ID: 2086458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunogenicity of free and carrier-conjugated peptides derived from the constant regions of a polymorphic malarial surface antigen.
    Jones GL; Lord R; Spencer L; Saul A
    Immunol Lett; 1991 Mar; 27(3):209-14. PubMed ID: 2060972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2.
    Jones GL; Spencer L; Lord R; Saul AJ
    Vaccine; 1996 Jan; 14(1):77-84. PubMed ID: 8821653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.
    Rzepczyk CM; Csurhes PA; Lord R; Matile H
    J Immunol; 1990 Oct; 145(8):2691-6. PubMed ID: 2212657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of maleimidocaproyloxysuccinimide to prepare malarial peptide carrier immunogens. Immunogenicity of the linking region.
    Jones GL; Edmundson HM; Spencer L; Gale J; Saul A
    J Immunol Methods; 1989 Oct; 123(2):211-6. PubMed ID: 2478635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological fine structure of the variable and constant regions of a polymorphic malarial surface antigen from Plasmodium falciparum.
    Jones GL; Edmundson HM; Lord R; Spencer L; Mollard R; Saul AJ
    Mol Biochem Parasitol; 1991 Sep; 48(1):1-9. PubMed ID: 1779984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two immunogenic peptide conjugates derived from P. falciparum MSA2 give rise to antibodies that crossreact with a nonhomologous 195-kDa malarial protein.
    Lord R; Jones G; Saul A
    Pept Res; 1993; 6(4):191-4. PubMed ID: 8400614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and antigenic reactivity of a carrier-free synthetic peptide complex derived from a 70-kDa Plasmodium falciparum exoantigen.
    James MA; Montenegro-James S; Fajfar-Whetstone C
    Parasitol Res; 1993; 79(6):501-7. PubMed ID: 8415567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid sequences recognized by T cells: studies on a merozoite surface antigen from the FCQ-27/PNG isolate of Plasmodium falciparum.
    Rzepczyk CM; Csurhes PA; Baxter EP; Doran TJ; Irving DO; Kere N
    Immunol Lett; 1990 Aug; 25(1-3):155-63. PubMed ID: 1704345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model multiple antigenic and homopolymeric peptides from non-repetitive sequences of malaria merozoite proteins elicit biologically irrelevant antibodies.
    Ramasamy R; Kanagaratnam R; Chandanie PD; Kulachelvy K; Ramasamy MS; Dharmasena PM
    Biochim Biophys Acta; 1999 Jan; 1453(1):115-25. PubMed ID: 9989251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide.
    Kumar A; Arora R; Kaur P; Chauhan VS; Sharma P
    J Immunol; 1992 Mar; 148(5):1499-505. PubMed ID: 1371529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2.
    Saul A; Lord R; Jones GL; Spencer L
    J Immunol; 1992 Jan; 148(1):208-11. PubMed ID: 1727867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175.
    Sim BK; Carter JM; Deal CD; Holland C; Haynes JD; Gross M
    Exp Parasitol; 1994 May; 78(3):259-68. PubMed ID: 7512929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion.
    Sim BK; Orlandi PA; Haynes JD; Klotz FW; Carter JM; Camus D; Zegans ME; Chulay JD
    J Cell Biol; 1990 Nov; 111(5 Pt 1):1877-84. PubMed ID: 2229177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-titer antisera production using three adjuvants and peptide conjugates derived from malarial surface antigen MSA-2.
    Jones GL; Spencer L; Lord R; Edmundson H; Saul AJ
    Pept Res; 1991; 4(3):138-41. PubMed ID: 1823184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide vaccines derived from a malarial surface antigen: effects of dose and adjuvants on immunogenicity.
    Jones GL; Spencer L; Lord R; Mollard R; Pye D; Saul A
    Immunol Lett; 1990 Jul; 24(4):253-60. PubMed ID: 1697281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody and clinical responses in volunteers to immunization with malaria peptide-diptheria toxoid conjugates.
    Ramasamy R; Wijesundere DA; Nagendran K; Ramasamy MS
    Clin Exp Immunol; 1995 Feb; 99(2):168-74. PubMed ID: 7851007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence comparison of allelic forms of the Plasmodium falciparum merozoite surface antigen MSA2.
    Thomas AW; Carr DA; Carter JM; Lyon JA
    Mol Biochem Parasitol; 1990 Dec; 43(2):211-20. PubMed ID: 2090943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antibody avidity and titre elicited by peptide as a protein conjugate or as expressed in vaccinia.
    Lew AM; Anders RF; Edwards SJ; Langford CJ
    Immunology; 1988 Oct; 65(2):311-4. PubMed ID: 3056855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.
    Chougnet C; Troye-Blomberg M; Deloron P; Kabilan L; Lepers JP; Savel J; Perlmann P
    J Immunol; 1991 Oct; 147(7):2295-301. PubMed ID: 1717554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.